Estimating health state utilities for aromatic L-amino acid decarboxylase deficiency (AADCd) in the United States
2025 · Health and Quality of Life Outcomes · 1 citations
https://doi.org/10.1186/s12955-025-02335-5
B
Berrin Monteleone
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
23
Papers
236
Citations
7
h-index
6
i10-index
Berrin Monteleone is an academic researcher from New York University. The author has contributed to research in topics: Metabolism and Genetic Disorders & Genetics and Neurodevelopmental Disorders & Genomics and Rare Diseases. The author has an h-index of 7, co-authored 20 publications.
ORCID: 0000-0001-6268-4995Papers by this author
worksP078: Carnitine palmitoyltransferase-2 deficiency in a 4-year-old boy presenting with autism spectrum disorder: Continuing to uncover links between autism and carnitine
2025 · Genetics in Medicine Open · 0 citations
https://doi.org/10.1016/j.gimo.2025.102922
EE402 Cost-Effectiveness Analysis of Eladocagene Exuparvovec-tneq for Aromatic L-Amino Acid Decarboxylase Deficiency (AADC-D) and Comparison with Other Rare Disease One-Time Treatments in the United States
2025 · Value in Health · 0 citations
https://doi.org/10.1016/j.jval.2025.04.2001
Eladocagene Exuparvovec for the Treatment of Aromatic l-Amino Acid Decarboxylase Deficiency (AADCd): An Economic Evaluation from a US Perspective
2025 · PharmacoEconomics · 0 citations
https://doi.org/10.1007/s40273-025-01542-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat